Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF. Eberle J, et al. Among authors: trefzer u. Drug Resist Updat. 2007 Dec;10(6):218-34. doi: 10.1016/j.drup.2007.09.001. Epub 2007 Dec 3. Drug Resist Updat. 2007. PMID: 18054518 Review.
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study.
Dummer R, Guminksi A, Gutzmer R, Lear JT, Lewis KD, Chang ALS, Combemale P, Dirix L, Kaatz M, Kudchadkar R, Loquai C, Plummer R, Schulze HJ, Stratigos AJ, Trefzer U, Squittieri N, Migden MR. Dummer R, et al. Among authors: trefzer u. Br J Dermatol. 2020 Jun;182(6):1369-1378. doi: 10.1111/bjd.18552. Epub 2019 Dec 8. Br J Dermatol. 2020. PMID: 31545507 Free PMC article.
Multiple melanoma metastases in split-thickness skin graft donor sites.
Trefzer U, Schwürzer-Voit M, Audring H, Jahn S, Thies E, Sterry W. Trefzer U, et al. J Am Acad Dermatol. 1998 Jun;38(6 Pt 1):997-8. doi: 10.1016/s0190-9622(98)70166-5. J Am Acad Dermatol. 1998. PMID: 9632014 No abstract available.
A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma.
Trefzer U, Weingart G, Chen Y, Adrian K, Audring H, Winter H, Guo YJ, Sterry W, Walden P. Trefzer U, et al. Adv Exp Med Biol. 1998;451:519-25. doi: 10.1007/978-1-4615-5357-1_80. Adv Exp Med Biol. 1998. PMID: 10026921 Clinical Trial. No abstract available.
Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma.
Trefzer U, Weingart G, Chen Y, Herberth G, Adrian K, Winter H, Audring H, Guo Y, Sterry W, Walden P. Trefzer U, et al. Int J Cancer. 2000 Mar 1;85(5):618-26. doi: 10.1002/(sici)1097-0215(20000301)85:5<618::aid-ijc4>;2-z. Int J Cancer. 2000. PMID: 10699939 Clinical Trial.
Expression of cyclooxygenase 2 in human malignant melanoma.
Denkert C, Köbel M, Berger S, Siegert A, Leclere A, Trefzer U, Hauptmann S. Denkert C, et al. Among authors: trefzer u. Cancer Res. 2001 Jan 1;61(1):303-8. Cancer Res. 2001. PMID: 11196178
Cytokines: interleukin and interferon therapy in dermatology.
Asadullah K, Sterry W, Trefzer U. Asadullah K, et al. Among authors: trefzer u. Clin Exp Dermatol. 2002 Oct;27(7):578-84. doi: 10.1046/j.1365-2230.2002.01144.x. Clin Exp Dermatol. 2002. PMID: 12464153 Review.
Malignant melanoma arising in a radiotherapy field: report of two cases and review of the literature.
Trefzer U, Voit C, Milling A, Audring H, Sterry W. Trefzer U, et al. Dermatology. 2003;206(3):265-8. doi: 10.1159/000068891. Dermatology. 2003. PMID: 12673088 Review.
Cytokine and anticytokine therapy in dermatology.
Trefzer U, Hofmann M, Sterry W, Asadullah K. Trefzer U, et al. Expert Opin Biol Ther. 2003 Aug;3(5):733-43. doi: 10.1517/14712598.3.5.733. Expert Opin Biol Ther. 2003. PMID: 12880374 Review.
Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG).
Zimpfer-Rechner C, Hofmann U, Figl R, Becker JC, Trefzer U, Keller I, Hauschild A, Schadendorf D. Zimpfer-Rechner C, et al. Among authors: trefzer u. Melanoma Res. 2003 Oct;13(5):531-6. doi: 10.1097/00008390-200310000-00012. Melanoma Res. 2003. PMID: 14512795 Clinical Trial.
125 results
Jump to page